Back

Impact of hypochloremia on mortality in heart failure patients: systematic review and metanalysis.

26 August 2023 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: determinants of outcome Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kamil Stankowski

Monzino Cardiology Centre, Milan (Italy)

7 More presentations in this session

Presentation thumbnail
The prognostic impact of cardio-renal anaemia syndrome in Japanese acute decompensated heart failure patients stratified by left ventricular ejection fraction
Mr T. Moriki (Kochi, JP)
Abstract Slides Video
Presentation thumbnail
Consistent excess mortality risk after heart failure onset in patients with atrial fibrillation, survival trends over 30 years of follow up, a nationwide registry-based study
Doctor E. Choha (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
The association between left ventricular ejection fraction and long-term survival: a large hospital-based cohort study in taiwan
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Efficacy of intravenous iron therapy in iron-deficient patients with heart failure: an updated systematic review and meta-analysis
Mr M. Freitas (Imperatriz, BR)
Abstract Slides Video
Presentation thumbnail
Impact of eGFR slope upon mortality in a real world heart failure cohort
Doctor M. Vanderheyden (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: determinants of outcome

The Event

Event poster

ESC Congress 2023

26 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of serum chloride levels in patients with implantable cardioverter defibrillators, relating to heart failure
thumbnail
Congress Presentation
Chloride: an emergent biomarker with prognostic significance in acute cardiorenal syndrome
thumbnail
Congress Presentation
Lower serum chloride levels are associated with worse functional status and higher clinical burden in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources